EuroRec: Euroropean institute for health records
USERNAME:      PASSWORD:   REMEMBER ME:   
SEARCH: 

European Medical Information Framework


Summary

European Medical Information Framework The EMIF project aims to develop a common information framework of patient-level data that will link up and facilitate access to diverse medical and research data sources, opening up new avenues of research for scientists. To provide a focus and guidance for the development of the framework, the project will focus initially on questions relating to obesity and Alzheimer’s disease.

Participants

EFPIA

  • GlaxoSmithKline Research and Development Ltd, Brentford, UK
  • Amgen NV, Brussels, Belgium
  • Boehringer Ingelheim International GmbH, Ingelheim, Germany
  • F. Hoffmann-La Roche AG, Basel, Switzerland
  • Institut de Recherches Internationales Servier, Suresnes, France
  • Janssen Pharmaceutica NV, Beerse, Belgium
  • Novo Nordisk A/S, Bagsværd, Denmark
  • Pfizer Limited, Sandwich, UK
  • UCB Pharma SA, Brussels, Belgium

Universities, research organisations, public bodies, non-profit groups

  • Erasmus Universitair Medisch Centrum Rotterdam, Rotterdam, Netherlands
  • Aarhus Universitetshospital, Aarhus Sygehus, Aarhus, Denmark
  • Agenzia Regionale di Sanita, Florence, Italy
  • Assistance Publique - Hôpitaux de Paris , Paris, France
  • Brighton Collaboration Foundation, Basel, Switzerland
  • Ealing Hospital NHS Trust, Southall, UK
  • European Institute for Health Records, Lille, France
  • European Molecular Biology Laboratory, Heidelberg, Germany
  • Fondazione PENTA - for the Treatment and Care of Children with HIV-ONLUS, Padova, Italy
  • Göteborgs Universitet, Gothenburg, Sweden
  • Helsingin Yliopisto, Helsinki, Finland
  • Institut für Epidemiologie und Präventionsforschung GmbH, Bremen, Germany
  • Institut National de la Santé et de la Recherche Médicale, Paris, France
  • Itä-Suomen Yliopisto, Kuopio, Finland
  • Karolinska Institutet, Stockholm, Sweden
  • King’s College London, London, UK
  • Maastricht University, Maastricht, Netherlands
  • Max-Planck-Gesellschaft zur Förderung der Wissenschaften, Munich, Germany
  • Medical Research Council UK, Swindon , UK
  • Provincia Lombardo-Veneta - Ordine Ospedaliero di San Giovanni di Dio— Fatebenefratelli, Milan, Italy
  • Tartu Ulikool, Tartu, Estonia
  • Teknologian tutkimuskeskus VTT, Espoo, Finland
  • Universidade de Aveiro, Aveiro, Portugal
  • Università degli Studi di Pisa, Pisa, Italy
  • Universität Leipzig, Leipzig, Germany
  • Universitat Pompeu Fabra, Barcelona, Spain
  • Universiteit Antwerpen, Antwerp, Belgium
  • University College London, London, UK
  • University of Cambridge, Cambridge, UK
  • University of Copenhagen, Copenhagen, Denmark
  • University of Glasgow, Glasgow, UK
  • University of Leicester, Leicester, UK
  • University of Manchester, Manchester, UK
  • University Pierre et Marie Curie, Paris, France
  • Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en Patiëntenzorg, Amsterdam, Netherlands
  • VIB, Zwijnaarde, Belgium

Patients’ organisations

  • Alzheimer Europe, Luxembourg, Luxembourg
  • Universitätsklinikum Erlangen, Anstalt des Öffentlichen Rechts, Erlangen, Germany
  • Vestische Kinder- und Jugendklinik Datteln, Dattien, Germany

SMEs

  • Concentris Research Management GmbH, Fürstenfeldbruck, Germany
  • Custodix NV, Sint-Martens-Latem, Belgium
  • Electrophoretics Ltd, Cobham, UK
  • GENOMEDICS S.R.L., Florence, Italy
  • MAAT France, Archamps, France
  • Pharmo Cooperatie UA, Utrecht, Netherlands
    Synapse Research Management Partners S.L., Barcelona, Spain
  • Societa Servizi Telematici SRL, Padova, Italy• Synapse Research Management Partners S.L., Barcelona, Spain 
Facts & Figures
Start date 01/10/2012
Duration 60 months
   
Contributions  
IMI funding 24 400 000
EFPIA in kind 24 100 000
Other   7 900 000
Total cost 56 400 000
Contact

Project Coordinator
Bart Vannieuwenhuyse

Janssen Pharmaceutica NV
Tel: +32 14 600320
E-mail: BVANNIEU[AT]its.jnj.com

Co-coordinator
Simon Lovestone
King's College London
Tel: +44 20 7848 0239
E-mail: simon.lovestone[AT]kcl.ac.uk

Managing Entity
Johan van der Lei

Erasmus Universitair Medisch Centrum Rotterdam
Tel: +31 10 70 441 22
E-mail: j.vanderlei[AT]erasmusmc.nl